NAD+ in Albuquerque: Understanding Who May Be a Candidate — and Who Should Proceed With Caution

Nicotinamide adenine dinucleotide — NAD+ — is a coenzyme found in every living cell, playing a central role in the biochemical processes that generate energy and maintain cellular function. As research into longevity and metabolic health has expanded, so has interest in NAD+ as a compounded preparation administered by injection or infusion. It carries no FDA-approved indication, meaning any clinical use falls into the category of off-label or compounded therapy evaluated on a patient-by-patient basis by a licensed provider.

For patients in Albuquerque and surrounding communities like Rio Rancho, Santa Fe, and the Northeast Heights, understanding whether a consultation about NAD+ is appropriate for your personal health situation is the most important first step — before focusing on what the therapy might do. This article is designed to help you build that foundational understanding so you can have an informed, productive conversation with a qualified medical provider.

Which Patient Profiles May Be Appropriate for a Provider Evaluation?

No two patients are identical, and a provider's assessment will always begin with your individual medical history, current health status, and goals. That said, certain profiles tend to generate the most clinically relevant conversations around NAD+ therapy:

• Adults experiencing persistent fatigue not explained by a primary condition: Patients who have ruled out common causes of fatigue — thyroid dysfunction, anemia, sleep disorders — and are curious about cellular energy support may prompt a provider to explore NAD+ as part of a broader wellness plan.
• Individuals focused on healthy aging and longevity: Early-phase human research and animal model data suggest NAD+ levels decline with age. Adults in midlife or later who are proactively engaged in evidence-informed longevity strategies may find this a worthwhile discussion point with their provider.
• Patients with metabolic health goals: Some research is exploring NAD+ in the context of metabolic function, though the evidence base is still developing and conclusions should not be overstated.
• Those who have tried oral NAD+ precursors: Some patients who have previously used oral supplements such as NMN or NR and want to discuss whether an injectable or infusion route may offer different bioavailability characteristics are candidates for a clinical conversation — not necessarily for the therapy itself.

Who Should Approach With Caution — or Avoid This Therapy?

Equally important is recognizing when NAD+ compounded therapy is likely to be contraindicated or requires a more careful, multidisciplinary assessment. Providers will typically pause or decline to proceed in the following circumstances:

• Pregnancy: NAD+ compounded preparations are contraindicated in pregnancy. If you are pregnant or planning to become pregnant, inform your provider before any consultation discussion about this therapy.
• Active malignancy: Patients with a current or recently active cancer diagnosis should not pursue NAD+ therapy without explicit oncology clearance. The role of cellular energy pathways in cancer biology makes this a critical safety consideration that requires specialist input.
• History of serious allergic reactions: Although rare, allergic reactions to compounded injectable preparations can occur. A provider will review your allergy history carefully before recommending any injectable therapy.
• Patients seeking a first-line treatment for a diagnosed condition: NAD+ is not an approved treatment for any medical condition. If you have a diagnosed illness, your primary or specialist care should remain the foundation of your treatment plan.

What Clinical Factors Does a Provider Weigh?

When a patient in Albuquerque sits down — or connects via telehealth — with a VidaVital provider to discuss NAD+, the evaluation is a clinical process, not a transaction. Providers typically consider your complete medication list (to identify potential interactions), your baseline health status, your realistic goals, and whether the administration route (injectable versus infusion) is appropriate for your needs and comfort. Lab work categories are determined by the provider based on your individual presentation. The provider also weighs whether the current evidence level — described as moderate, with some human clinical data and more research still needed — is sufficient justification given your specific circumstances. This patient-centered process is why a consultation exists: to make that determination together.

I live in Rio Rancho and I've been reading about NAD+ infusions online. Can I just show up and get one at the Albuquerque clinic?

NAD+ infusion therapy is not something a reputable clinic dispenses on demand. At VidaVital Medical in Albuquerque, the process begins with a provider evaluation — either in-clinic at 7920 Wyoming Blvd NE, Ste B-2, or via New Mexico-licensed telehealth where clinically appropriate. During that evaluation, your provider reviews your health history, goals, current medications, and any relevant lab data they determine is needed. Only after that assessment can a provider determine whether NAD+ compounded therapy is appropriate for you, and in what form and dose. The drive from Rio Rancho is short, and free on-site parking is available, but calling ahead at (505) 537-8484 to schedule a consultation is the right first step — not a walk-in infusion.

Who Should Discuss NAD+ With a Provider?

• Adults who have addressed common causes of fatigue and want to explore cellular energy support options with a clinician.
• Individuals in midlife or later who are building a structured, evidence-informed approach to healthy aging.
• Patients who have used oral NAD+ precursor supplements and want a professional assessment of whether injectable options are worth discussing.
• People with metabolic wellness goals who want to understand whether NAD+ research is relevant to their health picture.
• Anyone curious about compounded injectable or infusion therapies who wants an honest, medically supervised evaluation before making any decisions.

Preparing for Your Consultation

1. Write down your primary health concerns and wellness goals in plain language — your provider needs to understand what you're hoping to address.
2. Compile a complete list of current medications, supplements, and any oral NAD+ precursors you are already taking.
3. Note any known allergies, especially reactions to injectable preparations or infusions.
4. Be prepared to disclose your full medical history, including any current or past cancer diagnoses, so your provider can assess contraindications accurately.
5. If you are pregnant or may be pregnant, disclose this immediately — NAD+ compounded therapy is contraindicated in pregnancy.
6. Prepare specific questions about the evidence level, administration process, potential side effects (including injection-site reactions and mild GI discomfort), and what follow-up looks like.
7. Ask your provider what baseline labs, if any, they recommend for your specific situation before proceeding.

Consulting at the Albuquerque VidaVital Clinic

VidaVital Medical's Albuquerque location is situated at 7920 Wyoming Blvd NE, Ste B-2, Albuquerque, NM 87109 — conveniently accessible from I-40 and the Pan American Freeway, with free on-site parking. Patients from nearby communities including Rio Rancho, Santa Fe, Northeast Heights, Westside, and Nob Hill regularly use this location. For patients who may not be able to attend in person, New Mexico-licensed telehealth consultations are available where clinically appropriate, allowing the initial evaluation to occur remotely before any in-clinic procedures are considered. To schedule a consultation or ask preliminary questions, contact the clinic directly at (505) 537-8484. Keep in mind that scheduling a consultation is the beginning of a clinical process — it is not a commitment to any particular therapy.

Request a consultation at the Albuquerque clinic

To learn whether NAD+ may be appropriate for your goals, request a consultation with a VidaVital Medical provider. The Albuquerque clinic is at 7920 Wyoming Blvd NE, Ste B-2, Albuquerque, NM 87109. Call (505) 537-8484 or submit the online consultation-request form. Telehealth is available for patients located in New Mexico, with a New Mexico-licensed provider, where clinically appropriate. All treatment decisions follow a live provider evaluation — no prescription is implied or guaranteed by requesting a consultation.